Chengdu Kanghong Stock Hits Day High with Strong 3.25% Intraday Surge

Chengdu Kanghong Pharmaceutical Group Co., Ltd. has experienced a notable increase of 3.25% on March 6, 2026, reaching an intraday high of CNY 28.18. This performance stands in contrast to the China Shanghai Composite, which only rose by 0.38% on the same day. Over the past year, Chengdu Kanghong has demonstrated impressive growth, with a return of 43.28%, significantly outperforming the broader market index, which recorded a gain of 21.98%. However, the stock has faced some challenges in the short term, with a decline of 4.45% over the past week and a year-to-date drop of 6.77%. The company, operating within the Pharmaceuticals & Biotechnology sector, boasts a market capitalization of CNY 19,816 million. Key financial metrics include a return on equity of 13.70% and a price-to-book ratio of 3.79, indicating a solid valuation. Additionally, the company has a high dividend yield of 1.6%, reflecting its commitment to returning value to shareholders. Overall, Chengdu Kanghong continues to show resilience and a strong market position within its industry.